323 related articles for article (PubMed ID: 18544432)
1. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
Wong WY; Huang WC; Miller R; McGinty K; Whisnant JK
Haemophilia; 2000 Jan; 6(1):50-4. PubMed ID: 10632743
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Scharrer I
Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
Petrini P; Klementz G
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S143-6. PubMed ID: 9819046
[TBL] [Abstract][Full Text] [Related]
7. Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency.
Chuansumrit A; Visanuyothin N; Puapunwattana S; Chaivisuth A; Rasmidat P; Charoenkwan P; Chiemchanya S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1059-64. PubMed ID: 12549776
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
[TBL] [Abstract][Full Text] [Related]
9. Surgery in patients with congenital factor VII deficiency - a single center study.
Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
[TBL] [Abstract][Full Text] [Related]
10. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
[TBL] [Abstract][Full Text] [Related]
12. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
Liu N; Aldea S; François D; Cherqui-Michel M; Giansily-Blaizot M; Fischler M
Br J Anaesth; 2009 Dec; 103(6):858-60. PubMed ID: 19846405
[TBL] [Abstract][Full Text] [Related]
14. Long-term prophylaxis in severe factor VII deficiency.
Siboni SM; Biguzzi E; Mistretta C; Garagiola I; Peyvandi F
Haemophilia; 2015 Nov; 21(6):812-9. PubMed ID: 25952977
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
16. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor development after liver transplantation in congenital factor VII deficiency.
See WS; Chang KO; Cheuk DK; Leung YY; Chan GC; Chan SC; Ha SY
Haemophilia; 2016 Sep; 22(5):e417-22. PubMed ID: 27501477
[TBL] [Abstract][Full Text] [Related]
18. [Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor].
Antić D; Elezović I; Sufajdzić N; Todorović M; Bila J; Mitrović M; Andjelkovic N
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():218-21. PubMed ID: 19562872
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
[TBL] [Abstract][Full Text] [Related]
20. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
